Patents by Inventor MARIE-CHRISTINE DUBS-POTERSZMAN

MARIE-CHRISTINE DUBS-POTERSZMAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antagonists Of The Oncongenic Activity Of The Protein MDM2, And Use Thereof In the Treatment of Cancers
    Publication number: 20140030319
    Abstract: The present invention relates to the utilization of a compound capable of antagonizing at least partially the oncogenic activity of the protein Mdm2 for the preparation of a pharmaceutical composition intended more particularly to a treatment of cancers with no p53 context. It further relates to the viral vector comprising a nucleic acid sequence coding for a compound capable of inhibiting at least partially the oncogenic activity of the protein Mdm2, and to a corresponding pharmaceutical composition.
    Type: Application
    Filed: March 15, 2013
    Publication date: January 30, 2014
    Inventors: BRUNO TOCQUE, BOHDAN WASLYK, MARIE-CHRISTINE DUBS-POTERSZMAN
  • Antagonist of the oncogenic activity of the protein MDM2, and use thereof in the treatment of cancers
    Publication number: 20080311608
    Abstract: The present invention relates to the utilization of a compound capable of antagonizing at least partially the oncogenic activity of the protein Mdm2 for the preparation of a pharmaceutical composition intended more particularly to a treatment of cancers with no p53 context. It further relates to the viral vector comprising a nucleic acid sequence coding for a compound capable of inhibiting at least partially the oncogenic activity of the protein Mdm2, and to a corresponding pharmaceutical composition.
    Type: Application
    Filed: January 10, 2007
    Publication date: December 18, 2008
    Inventors: Bruno Tocque, Bohdan Wasylyk, Marie-Christine Dubs-Poterszman
  • Antagonists of the oncogenic activity of the MDM2, and use thereof in the treatment of cancers
    Publication number: 20040209834
    Abstract: The present invention relates to the utilization of a compound capable of antagonizing at least partially the oncogenic activity of the protein Mdm2 for the preparation of a pharmaceutical composition intended more particularly to a treatment of cancers with no p53 context. It further relates to the viral vector comprising a nucleic acid sequence coding for a compound capable of inhibiting at least partially the oncogenic activity of the protein Mdm2, and to a corresponding pharmaceutical composition.
    Type: Application
    Filed: December 1, 2003
    Publication date: October 21, 2004
    Inventors: Bruno Tocque, Bohdan Wasylyk, Marie-Christine Dubs-Poterszman
  • ANTAGONISTS OF THE ONCOGENIC ACTIVITY OF THE PROTEIN MDM2, AND USE THEREOF IN THE TREATMENT OF CANCERS
    Publication number: 20030060432
    Abstract: The present invention relates to the utilization of a compound capable of antagonizing at least partially the oncogenic activity of the protein Mdm2 for the preparation of a pharmaceutical composition intended more particularly to a treatment of cancers with no p53 context. It further relates to the viral vector comprising a nucleic acid sequence coding for a compound capable of inhibiting at least partially the oncogenic activity of the protein Mdm2, and to a corresponding pharmaceutical composition.
    Type: Application
    Filed: March 23, 1998
    Publication date: March 27, 2003
    Inventors: BRUNO TOCQUE, BOHDAN WASYLYK, MARIE-CHRISTINE DUBS-POTERSZMAN